Back
Silence Therapeutics Plc 10K Form
Sell
39
SLNCF
Silence Therapeutics Plc
Last Price:
$1.60
Seasonality Move:
18.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SLNCF News And Ratings
See the #1 stock for the next 7 days that we like better than SLNCF
SLNCF Financial Statistics
Sales & Book Value
| Annual Sales: | $43.3M |
|---|---|
| Cash Flow: | $-11M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.52 |
| Price / Book: | 3.06 |
Profitability
| EPS (TTM): | -0.79100 |
|---|---|
| Net Income (TTM): | $-112M |
| Gross Margin: | $31.2M |
| Return on Equity: | -101.79% |
| Return on Assets: | -58.13% |
Silence Therapeutics Plc Earnings Forecast
Key Silence Therapeutics Plc Financial Ratios
-
The Gross Profit Margin over the past 31 years for SLNCF is 72.10%.
-
The Selling, General & Administrative Expenses for SLNCF have been equal to 62.15% of Gross Profit Margin.
-
The Research & Development expenses have been 125.17% of Revenue.
-
The Net Earning history of SLNCF is -104.74% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 12 years.
Silence Therapeutics Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Current Symbol: | SLNCF |
| Website: | silence-therapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.69 |
| Quick Ratio: | 5.88 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SLNCF Technical Analysis vs Fundamental Analysis
Sell
39
Silence Therapeutics Plc (SLNCF)
is a Sell
Is Silence Therapeutics Plc a Buy or a Sell?
-
Silence Therapeutics Plc stock is rated a SellThe current Silence Therapeutics Plc [SLNCF] share price is $1.60. The Score for SLNCF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.